Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression

Lancet

Volumn 348, Issue 9028, 1996, Pages 643-648

  Ratcliffe, P J ^a   Dudley, C R K ^a   Higgins, R M ^a   Firth, J D ^a   Smith, B ^a   Morris, P J ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AZATHIOPRINE; CHOLESTEROL; CREATININE; CYCLOSPORIN; HEMOGLOBIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; STEROID;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG WITHDRAWAL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; TREATMENT OUTCOME;

EID: 0030573809     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)02510-X     Document Type: Article

References (30)

1. 1 Calne RY, Thiru S, McMaster P, et al. Cyclosporin in patients receiving renal allografts from cadaver donors. Lancet 1978; ii: 1323-27.
2. 2 European Multicentre Trial. Cyclosporin A as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Lancet 1982; ii: 57-60.
3. 3 Griffin PJA, Gomes Da Costa CA, Salaman JR. A controlled trial of steroids in cyclosporine-treated renal transplant recipients. Transplantation 1987; 43: 505-08.
4. 4 Johnson RWG, Mallick NP, Bakran A, et al. Cadaver renal transplantation without maintenance steroids. Transplant Proc 1989; 21: 1581-82.
5. 5 Tarantino A, Aroldi A, Stucchi L, et al. A randomized prospective trial comparing cyclosporine monotherapy with triple-drug therapy in renal transplantation Transplantation 1991; 52: 53-57.
6. 6 Hricik DE, O'Toole MA, Schulak JA, Herson J. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 1993; 4: 1300-05.
7. 7 Restifo AC, Petrie JJB, Rigby RJ, et al. A comparison of triple therapy with double therapy (cyclosporine/azathioprine) in low-risk, first cadaveric renal allograft recipients. Transplant Proc 1989; 21: 1604-05.
8. 8 Stratta RJ, Armbrust MJ, Oh C-S, et al. Withdrawal of steroid immunosuppression in renal transplant recipients. Transplantation 1988; 45: 323-28.
9. 9 Kupin W, Venkat KK, Oh HK. Dienst S. Complete replacement of methylprednisolone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients. Transplantation 1988; 45: 53-55.
10. 10 O'Connell PJ, D'Apice AJF, Walker RG, et al. Results of steroid withdrawal in renal allograft recipients on low-dose cyclosporine A, azathioprine and prednisolone. Clin Transplant 1988; 2: 102-06.
11. 11 Maiorca R, Cristinelli L, Brunori G, et al. Propective controlled trial of steroid withdrawal after six months in renal transplant patients treated with cyclosporine. Transplant Proc 1988; 20: 121-25.
12. 12 Reisman L, Lieberman KV, Burrows L, Schanzer H. Follow-up of cyclosporine treated pediatric renal allograft recipients after cessation of prednisolone. Transplantation 1990; 49: 76-80.
13. 13 Schulak JA, Mayes JT, Moritz CE, Hricik DE. A prospective randomized trial of prednisolone versus no prednisolone maintenance therapy in cyclosporine-treated and azathioprine-treated renal transplant patients. Transplantation 1990; 49: 327-32.
14. 14 Tamm M, Thiel G, Huser B, et al. Cyclosporine monotherapy after kidney transplantation since 1983. Transplant Proc 1991; 23: 997-98.
15. 15 Sinclair NRS, for the Canadian Multicentre Transplant Study Group. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. Can Med Assoc J 1992; 147: 645-57.
16. 16 Hricik DE, Whalen CC, Lautman J, et al. Withdrawal of steroid after renal transplantation - clinical predictors of outcome. Transplantation 1992; 53: 41-45.
17. 17 Ingulli E, Sharma V, Singh A, Suthanthiran M, Tejani A. Steroid withdrawal, rejection and the mixed lymphocyte reaction in children after renal transplantation. Kidney Int 1993; 44; S36-S39.
18. 18 Hricik DE, Almawi WY, Strom TB. Trends in the use of glucocorticoids in renal transplantation. Transplantation 1994; 57: 979-89.
19. 19 Opelz G. Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome. Transplantation 1994; 58: 443-46.
20. 20 Ingulli E, Tejani A, Markell M. The beneficial effects of steroid withdrawal on blood pressure and lipid profile in children posttransplantation in the cyclosporine era. Transplantation 1993; 55: 1029-33.
21. 21 Pirsch JD, Armbrust MJ, Knechtle SJ, et al. Effect of steroid withdrawal on hypertension and cholesterol levels in living related recipients. Transplant Proc 1991; 23: 1363-64.
22. 22 Hricik DE, Bartucci MR, Mayers JT, Schulak JA. The effects of steroid withdrawal on the lipoprotein profiles of cyclosporine-treated kidney and kidney-pancreas transplant recipients. Transplantation 1992; 54: 868-71.
23. 23 Hricik DE, Lautman J, Bartucci MR, et al. Variable effects of steroid withdrawal on blood pressure reduction in cyclosporine-treated renal transplant recipients. Transplantation 1992; 53: 1232-35.
24. 24 Hricik DE, Schulak JA. Metabolic effects of steroid withdrawal in adult renal transplant recipients. Kidney Int 1993; 44: S26-S29.
25. 25 Van Buren CT. Hyperlipidemia and hypertension: impact of steroid withdrawal. Transplant Proc 1993; 25: 30-32.
26. 26 Fabrega AJ, Cohan J, Meslar P, Pollak R. Effects of steroid withdrawal on long-term renal allograft recipients with posttransplantation diabetes mellitus. Surgery 1994; 116: 792-97.
27. 27 Kasiske BL, Umen AJ. Persistent hyperlipidemia in renal transplant patients. Medicine 1987; 66: 309-16.
28. 28 Bittar AE, Ratcliffe PJ, Richardson AJ, et al. The prevalence of hyperlipidemia in renal transplant recipients. Transplantation 1990; 50: 987-92.
29. 29 Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990; 112: 352-64.
30. 30 Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411-22.